Biotami Corporation has certain exclusive rights from The Gene Pool, Inc. to use Molecular Locks to make simple format NATs. Over two dozen Molecular Lock patents have issued worldwide to The Gene Pool, Inc. including in the U.S., China, and 15 countries in Europe. Patents issued or in prosecution are highlighted in the map in orange.

Biotami Corporation is seeking additional patent protection on its own simple format test inventions.